Liposomal amphotericin B (AmBisome) compared with amphotericin and both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis

AIDS

Volumn 11, Issue 12, 1997, Pages 1463-1471

  Leenders, Alexander C A P ^a   Reiss, Peter ^b,c   Portegies, Peter ^b   Clezy, Kate ^d   Hop, Wim C J ^e   Hoy, Jennifer ^f   Borleffs, Jan C C ^g   Allworth, Tony ^h   Kauffmann, Robert H ⁱ   Jones, Philip ^j   Kroon, Frank P ^k   Verbrugh, Henri A ^a,e   De Marie, Simon ^a,e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Natl AIDS Therapy Evaluation Centre   (Netherlands)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^f Fairfield Infect Disease Hospital   (Australia)

^g Academic Hospital Utrecht   (Netherlands)

^h ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

ⁱ LEYENBURG HOSPITAL   (Netherlands)

^j PRINCE HENRY HOSPITAL   (Australia)

^k LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

AmBisome; Amphotericin B; Cryptococcal meningitis; Cryptococcus neoformans; HIV; Liposomal amphotericin B; Randomized comparative trial

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CEREBROSPINAL FLUID CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FUNGAL MENINGITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 9844265398     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199712000-00010     Document Type: Article

References (29)

1. Dismukcs WF: Cryptococcal meningitis in patients with AIDS J Infect Dis 1988, 157:624-628.
2. Chuck Sl, Sando MA: Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989, 321:794-799.
3. Zugor A, Louie I, Holzman RS, Simberkoff MS, Rahal JJ: Cryptococcal disease in patients with the acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann Intern Med 1986, 104:234-240.
4. Saaj MS, Powderly WG, Cloud GA, et al.: Comparison of amphotericin B with fluconazole in the treatment of acute AlDS-associaled cryptococcal meningitis. N Engl J Med 1992, 326:83-86.
5. Larson RA, Leal MA, C'han LS: Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. Ann Intern Med 1990, 113:183-187.
6. Cans do J, Portogios P, Tiossons G, et al.: Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS 1992, 6:185-190.
7. Horsl van dor CM, Saag MS, Cloud GA, et al.: Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997, 337:15-21.
8. Saag M, Horsl van der C, Cloud G, et al.: Randomized double blind comparison of amphotericin B plus flucytosine to amphotericin B alone (step 1) followed by a comparison of fluconazole to itraconazole (step 2) in the treatment of acute cryptococcal meningitis in patients with AIDS: part 2. 15th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, September 1995 [abstract 1217].
9. Janknogl R, Mario do S, Bakker-Woudenberg IAJM, Crommelin JA: Liposomal and lipid formulations of amphotericin B: clinical pharmacokinetics. Clin Pharmacokinet 1992, 23:279-291.
10. Mario do S, Janknegt R, Bakkor-Woudonborg JAJM: Clinical use of liposomal and lipid-complexed amphotericin B. J Antimicrob Chemother 1994, 33:907- 916.
11. Graybill JR: Lipid formulations of ampholericin B: does the emperor need new clothes? Ann Intern Med 1996, 124:921-923.
12. Ng TTC , Donning DW: Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections Arch Intern Med I995, 155:1093-1098.
13. Loondors ACAP, do Marie S: The use of lipid formulations of amphotericin B for systemic fungal infections leukemia 1996, 10:1570-1575.
14. Cokor RJ, Viviani M, Gazard BG, et al.: Treatment of crypto- coccosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. AIDS 1993, 7:829-835.
15. Etton van F, Houvol van don-do Groot C, Bakker-Woudenberg IAJM: Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leukopenic mice. J Antimicrob Chemother 1991, 32:723-739.
16. Dixon WI (Fd): BMDP Statiscal Software Manual, BMDP-5V. Oxford: University of California Press; 1990:1207-1244.
17. Adlor-Mooro JP, Hhiang SM, Satorius A, et al.: Treatment of murine candidosis and cryptococcosis with unilamellar liposomal amphotericin B formulation. J Antimicrob Chemother 1991, 28 (suppl B):S63-S71.
18. Hostotlor jS, Clomons KV, Hanson LH, Stevens DA: Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosis. Antimicrob Agents Chemother 1992, 36:2656-2660.
19. Perfect JR, Wright KA: Amphotericin B lipid complex in the treatment of experimental cryptococcal meningitis and disseminated candidosis. J Antimicrob Chemother 1994, 33:73-81.
20. Albert MM, Stahl-Carroll TL, Luther MF, C.raybill JR: Comparison of liposomal amphotericin B to amphotericin B for treatment of murine cryplococcal meningitis. J Mycol Med 1995, 5:1-6
21. Sbarkoy PK, Graybill JR, Johnson ES, et al.: Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Intern Dis 1996, 22:315-321.
22. Loondors AC, Ende van dor ME, van der Res TC, do Marie S: Cryptococcal meningitis in HIV-infected patients [letter] AIDS 1994, 8:1741-1741.
23. Diamond RD, Bonnett JE: Prognostic factors in cryptococcal meningitis. Ann Intern Med 1974, 80:176-181.
24. Pokellwing JM (Ed): Handbook Klinisch-Chemische Tests. Utrecht: Bungo; 1995:98-100.
25. Arning M, Heer-Sonderhoff AH, Wehmeier A, Schneider W: Pulmonary toxicity during infusion of liposomal amphotericin B in two patients with acute leukemia. Eur J Clin Microbiol Infect Dis 1995, 14:41-43.
26. Proffitt RT, Satorius A, Chiang SM, Sullivan L, Adler-Moore J: Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. J Antimicrob Chemother 1991, 28 (suppl B):S49-S61.
27. Chandler FW, Kaplan W, Ajello L: A Colour Atlas and Textbook of the Histopathology of Mycotic Diseases. Weerl: Wolfe Medical Publications; 1989:190-198.
28. Denning DW, Tucker RM, Hanson LH, Hamilton JR, Stevens DA: Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 1989, 149:2301-2308.
29. Tollcmar J, Ringden O: Lipid formulations of amphotericin B. Less toxicity but at what economic cost?. Drug Satety 1995, 13:207-218.